posted
HGSI will be reporting their Benlysta (Lupus) PhaseIII trial news sometime on Monday. The stock has been moving higher for the past couple days and if the PIII results are positive, there's a huge potential for the stock to move from $3.40 to over $15.
They have partnered with Glaxo Smith Kleine and as of 2 weeks ago, there is a job opening on the Glaxo website for a "Senior Product Manager/Product Manager-Benlysta ".
This is shaping up to make a run like DNDN made back in March when their stock ran from $2.60 to over $20 after positive PIII trial of one of their drugs.
Obviously if the news isnt good, the stock will drop, but if the news is as good as most investors think it is, the stock will surge on monday.
If you want to take a shot, you should try to get in pre-market. I think the results will be released early morning.
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
